Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Proteome Science
|
October 15, 2008
Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation
Emilie Ernoult, Erick Gamelin, Catherine Guette
Cancer Research
|
February 5, 2008
The EGFR-STAT3 oncogenic pathway up-regulates the Eme1 endonuclease to reduce DNA damage after topoisomerase I inhibition
Arnaud Vigneron, Erick Gamelin, Olivier Coqueret
Therapie
|
June 22, 2007
[Detection of dihydropyrimidine dehydrogenase deficiency before treatment by fluoropyrimidines]
Erick Gamelin, Michèle Boisdron-Celle, Alain Morel
Journal of Biomedicine & Biotechnology
|
November 6, 2009
A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation
Emilie Ernoult, Anthony Bourreau, Erick Gamelin, et al.
Seminars in Oncology
|
November 8, 2002
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures
Erick Gamelin, Laurence Gamelin, Laura Bossi, et al.
Bulletin Du Cancer
|
February 24, 2006
[Oxaliplatin neurotoxicity]
Laurence Gamelin, Michèle Boisdron-Celle, Alain Morel, et al.
Cancer Research
|
October 6, 2005
Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1
Arnaud Vigneron, Igor B Roninson, Erick Gamelin, et al.
The Journal of Biological Chemistry
|
August 23, 2006
The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression
Arnaud Vigneron, Julia Cherier, Benjamin Barré, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 20, 2005
An accurate dihydrouracil/uracil determination using improved high performance liquid chromatography method for preventing fluoropyrimidines-related toxicity in clinical practice
Gaëlle Remaud, Michèle Boisdron-Celle, Catherine Hameline, et al.
Trends in Molecular Medicine
|
November 23, 2006
The STAT3 oncogene as a predictive marker of drug resistance
Benjamin Barré, Arnaud Vigneron, Neil Perkins, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Proteome Science
|
October 15, 2008
Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation
Emilie Ernoult, Erick Gamelin, Catherine Guette
Cancer Research
|
February 5, 2008
The EGFR-STAT3 oncogenic pathway up-regulates the Eme1 endonuclease to reduce DNA damage after topoisomerase I inhibition
Arnaud Vigneron, Erick Gamelin, Olivier Coqueret
Therapie
|
June 22, 2007
[Detection of dihydropyrimidine dehydrogenase deficiency before treatment by fluoropyrimidines]
Erick Gamelin, Michèle Boisdron-Celle, Alain Morel
Journal of Biomedicine & Biotechnology
|
November 6, 2009
A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation
Emilie Ernoult, Anthony Bourreau, Erick Gamelin, et al.
Seminars in Oncology
|
November 8, 2002
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures
Erick Gamelin, Laurence Gamelin, Laura Bossi, et al.
Bulletin Du Cancer
|
February 24, 2006
[Oxaliplatin neurotoxicity]
Laurence Gamelin, Michèle Boisdron-Celle, Alain Morel, et al.
Cancer Research
|
October 6, 2005
Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1
Arnaud Vigneron, Igor B Roninson, Erick Gamelin, et al.
The Journal of Biological Chemistry
|
August 23, 2006
The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression
Arnaud Vigneron, Julia Cherier, Benjamin Barré, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 20, 2005
An accurate dihydrouracil/uracil determination using improved high performance liquid chromatography method for preventing fluoropyrimidines-related toxicity in clinical practice
Gaëlle Remaud, Michèle Boisdron-Celle, Catherine Hameline, et al.
Trends in Molecular Medicine
|
November 23, 2006
The STAT3 oncogene as a predictive marker of drug resistance
Benjamin Barré, Arnaud Vigneron, Neil Perkins, et al.
Page
of 5